药效评价Rutaecarpine and evodiamine selected as β1-AR inhibitor candidates using β1-AR/CMC-offline-UPLC/MS prevent cardiac ischemia-reperfusion injury via energy modulation.
期刊:Journal of pharmaceutical and biomedical analysis发表年份:2015作者:Hui Xue; Yongjie Cheng; Xin Wang; Yuan Yue; Weifang Zhang; Xiaoni Li
